Peptron Inc Cash Flow Conversion Efficiency
Peptron Inc cash flow conversion efficiency. Based on the latest financial reports, Peptron Inc (087010) has a cash flow conversion efficiency ratio of -0.028x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.63 Billion ≈ $-2.46 Million USD) by net assets (₩129.48 Billion ≈ $87.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Peptron Inc (2014–2025)
Cash flow conversion efficiency of Peptron Inc from 2014 to 2025. This chart illustrates how Peptron Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 087010 share price today for real-time trading data and today's change.
Peptron Inc Cash Flow Conversion Ratio Explained
Peptron Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Peptron Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Peptron Inc ranked by their cash flow conversion efficiency. Also see market value of Peptron Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Econergy Renewable Energy Ltd
TA:ECNR
|
-0.003x |
|
PNC Process Systems Co Ltd
SHG:603690
|
0.012x |
|
KPC Pharmaceuticals Inc
SHG:600422
|
0.018x |
|
MAP Aktif Adiperkasa Tbk PT
JK:MAPA
|
0.093x |
|
Jiangsu Bojun Industrial Technology Co. Ltd
SHE:300926
|
0.019x |
|
Oric Pharmaceuticals Inc
NASDAQ:ORIC
|
-0.083x |
|
Life Healthcare
JSE:LHC
|
0.083x |
|
INVENTIVA ADS/1 O.N.
F:6IVA
|
N/A |
Annual Cash Flow Conversion Efficiency for Peptron Inc (2014–2025)
The table below shows the annual cash flow conversion efficiency of Peptron Inc from 2014 to 2025. Review how much free cash does Peptron Inc generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩142.01 Billion ≈ $96.24 Million |
₩-20.59 Billion ≈ $-13.95 Million |
-0.145x | -72.27% |
| 2024-12-31 | ₩151.71 Billion ≈ $102.81 Million |
₩-12.77 Billion ≈ $-8.65 Million |
-0.084x | +72.30% |
| 2023-12-31 | ₩36.13 Billion ≈ $24.48 Million |
₩-10.97 Billion ≈ $-7.44 Million |
-0.304x | -37.64% |
| 2022-12-31 | ₩53.11 Billion ≈ $35.99 Million |
₩-11.72 Billion ≈ $-7.94 Million |
-0.221x | -29.48% |
| 2021-12-31 | ₩62.28 Billion ≈ $42.21 Million |
₩-10.61 Billion ≈ $-7.19 Million |
-0.170x | +2.98% |
| 2020-12-31 | ₩77.13 Billion ≈ $52.27 Million |
₩-13.55 Billion ≈ $-9.18 Million |
-0.176x | +48.60% |
| 2019-12-31 | ₩28.09 Billion ≈ $19.03 Million |
₩-9.60 Billion ≈ $-6.51 Million |
-0.342x | -268.75% |
| 2018-12-31 | ₩45.10 Billion ≈ $30.56 Million |
₩-4.18 Billion ≈ $-2.83 Million |
-0.093x | +19.36% |
| 2017-12-31 | ₩48.95 Billion ≈ $33.17 Million |
₩-5.63 Billion ≈ $-3.81 Million |
-0.115x | -124.03% |
| 2016-12-31 | ₩53.21 Billion ≈ $36.06 Million |
₩-2.73 Billion ≈ $-1.85 Million |
-0.051x | +62.48% |
| 2015-12-31 | ₩17.23 Billion ≈ $11.67 Million |
₩-2.36 Billion ≈ $-1.60 Million |
-0.137x | +65.62% |
| 2014-12-31 | ₩7.18 Billion ≈ $4.87 Million |
₩-2.86 Billion ≈ $-1.94 Million |
-0.398x | -- |
About Peptron Inc
Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, … Read more